Depression News and Research

Latest Depression News and Research

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.

27 Jan 2012

Psychiatric disorders definitions to be revised

The definition of depression is proposed to be changed and now the diagnosis would characterize grieving as a disorder and greatly increase the number of people treated for it.

26 Jan 2012

Aspirin may reduce depressive symptoms in survivors of ACS

Aspirin has been commonly used for prevention of cardiovascular disease. Depression has been found to be an important prognostic factor after heart attacks. But what is their relationship? This is addressed by a study published in the 5th 2011 issue of Psychotherapy and Psychosomatics.

24 Jan 2012

Magic Mushroom’s compound may help in some mental disorders: Study

There has been little research on the mechanism of action of “magic mushrooms” on the brain. A growing number of studies suggested that perhaps the mushrooms' key ingredient could work magic for certain mental disorders. New research in Proceedings of the National Academy of Sciences sheds light on why one of the mushrooms' hallucinogenic chemical compounds, psilocybin, may hold promise for the treatment of depression.

24 Jan 2012

Women feel pain more than men: Study

A new study showed that women experience more intense pain than men. The study published in the Jan. 23 issue of the Journal of Pain, further suggests that greater effort is needed to recruit women into studies in order to determine the reasons for this gender difference. The Stanford University School of Medicine investigators examined pain scores from tens of thousands of patients in the United States.

24 Jan 2012

Possible link between vascular lesions and Alzheimer's disease

Approximately 20 percent of all stroke survivors will develop cognitive problems later in life, including vascular dementia. Experts with the Methodist Neurological Institute in Houston say recent research showing a possible link between vascular lesions and Alzheimer's disease is yet another reason to be more vigilant in our efforts to prevent a stroke.

24 Jan 2012

Potential role of omega-3 fatty acid in preventing psychological consequences of accidents

A report in the 5th 2011 issue of Psychotherapy and Psychosomatics suggests the potential role of omega-3 fatty acid in preventing the psychological consequences of an accident.

23 Jan 2012

Alexithymia associated with depression in de novo PD patients

Alexithymia has been found to be strongly associated with depression in both general and clinical populations. Alexithymic and depressive symptoms may be partially overlapping, but not all are correlated with depressive symptoms, thus underlining the relative independence of the two disorders. Parkinson's disease (PD) is a clinical condition often characterized by depression and an altered emotional processing. In medicated PD patients alexithymia has a prevalence of 21% and is related to depression.

23 Jan 2012

SSRI use raises risk of fall among elderly with dementia: Study

A new study reveals that nursing home residents with dementia who use selective serotonin reuptake inhibitors (SSRIs) have an increased risk of having a fall that causes injury compared with those who do not use SSRIs. Additionally those using average doses have 3 times the risk compared with nonusers, the authors, led by Carolyn S. Sterke, from Erasmus University Medical Center, Rotterdam, the Netherlands, report. Authors write, “Even at low doses, SSRIs are associated with increased risk of an injurious fall in nursing home residents with dementia.”

22 Jan 2012

Sex declared safe for heart patients

A doctors’ group on Thursday suggested that sex may be safe for most heart patients. The American Heart Association added that having sex only slightly raises the chance for a heart attack. And that’s true for people with and without heart disease. Despite the higher risk for a heart patient to have a second attack, there’s no evidence that they have more sex-related heart attacks than people without cardiac disease. The updated advice was released online Thursday in the heart association journal, Circulation.

22 Jan 2012

Study evaluates whether PWB predicts negative affectivity in fibromyalgia

Fibromyalgia (FM) is a stress-related functional somatic syndrome consisting of musculoskeletal pain and tenderness, and additional symptoms such as fatigue and difficulty concentrating. Factors such as ill-being, often assessed as negative affectivity, may follow, increasing the risk of unhealthy and dysfunctional lifestyles.

21 Jan 2012

Simplest, reinforced FDA warnings found effective

The impact of efforts by the U.S. Food and Drug Administration to notify the general public and health care providers about unanticipated risks from approved medications has been "varied and unpredictable," according to a systematic review of published studies about FDA warnings and alerts over the last 20 years.

20 Jan 2012

Study aims to help adult men and women with SAD

If winter's long nights and cold weather have you feeling depressed, a new research study could lift your spirits. The study, lead by Janis Anderson, PH.D., an associate psychologist in the Brigham and Women's Hospital Department of Psychiatry, aims to help adult (ages 21-64) men and women with Seasonal Affective Disorder (SAD) by comparing two new types of light technologies to determine which one works better.

20 Jan 2012

UTHealth's Center for Neurobehavioral Research on Addictions opens outpatient clinic

An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.

20 Jan 2012

Mylan introduces Levetiracetam to treat seizures

Mylan Inc. today announced that its Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL, 1000 mg/100 mL and 1500 mg/100 mL, for intravenous use.

19 Jan 2012

SSRIs increase risk of falling in nursing home residents with dementia

Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are three times more likely to have an injurious fall than similar people who don't use these drugs. The association can be seen in people who use low doses of SSRIs and the risk increases as people take higher doses. The results are published in the British Journal of Clinical Pharmacology.

19 Jan 2012

Mephedrone users would switch to a new legal high if it caused less harm

Since mephedrone was made illegal in the UK in 2010, the street price of the drug has risen while the quality has degraded, which in turn may have reduced use of the drug. New research published online today reveals that young people who continued to use mephedrone after it became illegal would switch to a new legal high if it were pure and rated highly by their friends or on the Internet.

19 Jan 2012

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12.

19 Jan 2012

Viewpoints: Health care is a civil right; A Medicare strategy based on Lenin

Martin Luther King Jr.'s legacy is one of progress toward a better life for every American, including equal opportunity in voting, housing, education, and employment. Reflecting on his legacy also means recognizing the steps we must take to address the inequalities that persist. Many of these involve health care. Poor and minority Americans suffer from more preventable diseases on average, lower-quality care, fewer treatment options, and less health insurance coverage.

18 Jan 2012

Insights into rates and impact of mTBI among military personnel in Iraq/Afghanistan

As the last U.S. troops return home from Iraq, new research lends timely insights into the rates and impact of mild traumatic brain injury (mTBI) among military personnel serving in Iraq/Afghanistan, according to a topical issue of The Journal of Head Trauma Rehabilitation (JHTR), the official journal of the Brain Injury Association of America.

18 Jan 2012